Michael Hearne Email
Chief Financial Officer . Odonate Therapeutics
How to contact Michael Hearne
Join and see Michael's contact info for free!Current Roles
Employees:
56Revenue:
$9.3MAbout
Odonate Therapeutics is dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Our initial focus is on the development of tesetaxel, an investigational, orally administered taxane. We are conducting our multinational, multicenter, randomized, Phase 3 study in locally advanced or metastatic breast cancer (MBC), known as CONTESSA. Our goal is to develop an effective chemotherapy choice for patients that provides quality-of-life advantages over current alternatives.Odonate Therapeutics Address
4747 Executive DriveSan Diego, CA
United States